The aim of this study was to identify and characterize binding sites for in
hibin in primary cultures of ovine anterior pituitary cells. Recombinant hu
man 31-kDa inhibin A was iodinated by an optimized lactoperoxidase procedur
e. Fractionation of the labeled protein by gel filtration chromatography on
Sephadex G-100 in 0.1 M HCl yielded two immunoactive peak regions, the sec
ond of which was bioactive as assessed by in vitro bioassay, with a ratio o
f bioactivity/immunoactivity of 0.62-0.77 and an iodine incorporation ratio
of 1.7-2.0 mol I-125/mol inhibin. The specific binding of purified [I-125]
inhibin to cultured ovine pituitary cells varied with time, temperature, an
d cell number. Displacement of the tracer by unlabeled inhibin, as assessed
by Scatchard analysis, revealed two binding sites with average K-d values
of 0.28 and 3.9 nM and with approximately 250 and 3100 binding sites/anteri
or pituitary cell, respectively. There was little cross-reaction between in
hibin and activin A (<2%), transforming growth factor-beta (<0.2%), or foll
istatin (much less than 0.1%), Examination of cell lines that were not expe
cted to have inhibin receptors showed that there was no specific binding of
inhibin to human leukemia (Jurkat) cells, whereas the binding to human emb
ryonic kidney (293) cells was displaced by both inhibin and activin with a
similar degree of crossreaction, which suggests binding to an activin recep
tor. It is concluded that inhibin-binding sites with high affinity and spec
ificity have been identified on ovine pituitary cells, consistent with both
inhibin action on the pituitary and the presence of the putative inhibin r
eceptor.